HT
MRVI icon

Headlands Technologies’s Maravai LifeSciences MRVI Stock Holding History

Headlands Technologies’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,272
Closed -$65.9K – 880
2025
Q4 		$65.9K Buy
+20,272
New +$68.2K 0.01% 643
2024
Q4 		– Sell
-37,071
Closed -$308K – 1448
2024
Q3 		$308K Buy
37,071
+22,136
+148% +$191K 0.04% 424
2024
Q2 		$107K Buy
14,935
+10,053
+206% +$86.8K 0.01% 630
2024
Q1 		$42.3K Buy
+4,882
New +$33K 0.01% 757
2023
Q3 		– Sell
-991
Closed -$12.3K – 1100
2023
Q2 		$12.3K Buy
+991
New +$13.4K ﹤0.01% 609

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Headlands Technologies's MRVI Position: Q1 2026 in Review

Headlands Technologies sold out of Maravai LifeSciences (MRVI) in Q1 2026, closing a stake of 20,272 shares — an estimated $65.9K sold.

Headlands Technologies first reported a position in MRVI in Q2 2023 and held it in 5 quarters. The position peaked at $308K in Q3 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Headlands Technologies reported no remaining Maravai LifeSciences position as of Q1 2026 after selling out during the quarter.
  • Headlands Technologies sold 20,272 Maravai LifeSciences shares in Q1 2026, an estimated $65.9K.
  • Headlands Technologies first reported a position in Maravai LifeSciences in Q2 2023 and held it in 5 quarters.
  • Headlands Technologies's Maravai LifeSciences position peaked at $308K in Q3 2024.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.